Zdrowie i gospodarka · 04/02/2022

FDA Classifies Photoplethysmograph Analysis Software for Over-the-Counter Use into Class II with Special Controls

The FDA has classified the photoplethysmograph analysis software for over-the-counter use into Class II with special controls, aiming to ensure the device's safety and effectiveness while expanding patient access to innovative devices.